Search research articles
Contact Us
Filters
Showing results (1-10 of 172) with videos related to
Page
of 18
Sort By:
Journal of Crohn'S & Colitis
|
March 28, 2020
Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
Giovanni Monteleone, Sandro Ardizzone
Nature Clinical Practice. Gastroenterology & Hepatology
|
November 3, 2005
Should azathioprine be withdrawn in patients with Crohn's disease who are in long-term remission?
Sandro Ardizzone, Gabriele Bianchi Porro
Drugs
|
November 4, 2005
Biologic therapy for inflammatory bowel disease
Sandro Ardizzone, Gabriele Bianchi Porro
Nature Clinical Practice. Gastroenterology & Hepatology
|
June 19, 2008
Is it possible to modify the clinical course of Crohn's disease?
Sandro Ardizzone, Gabriele Bianchi Porro
Inflammatory Bowel Diseases
|
September 26, 2008
How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?
Sandro Ardizzone, Gabriele Bianchi Porro
Drug Safety
|
July 13, 2002
Comparative tolerability of therapies for ulcerative colitis
Sandro Ardizzone, Gabriele Bianchi Porro
The American Journal of Gastroenterology
|
May 7, 2010
To stent or not to stent?: palliative management of inoperable colorectal cancer
Gianpiero Manes, Dario Callegaro, Sandro Ardizzone
Journal of Crohn'S & Colitis
|
December 4, 2013
Pneumatosis intestinalis and perforation in Crohn's disease: worrisome or not?
Emilia Bareggi, Massimo Tonolini, Sandro Ardizzone
Therapeutic Advances in Gastroenterology
|
July 2, 2016
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease
Sandro Ardizzone, Gerolamo Bevivino, Giovanni Monteleone
World Journal of Gastrointestinal Endoscopy
|
March 29, 2019
Endoscopic retrograde cholangiopancreatography, lights and shadows: Handle with care
Raffaele Salerno, Nicolò Mezzina, Sandro Ardizzone
Page
of 18
Search research articles
Search
Showing results (1-10 of 172) with videos related to
Sort By:
Page
of 18
Journal of Crohn'S & Colitis
|
March 28, 2020
Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
Giovanni Monteleone, Sandro Ardizzone
Nature Clinical Practice. Gastroenterology & Hepatology
|
November 3, 2005
Should azathioprine be withdrawn in patients with Crohn's disease who are in long-term remission?
Sandro Ardizzone, Gabriele Bianchi Porro
Drugs
|
November 4, 2005
Biologic therapy for inflammatory bowel disease
Sandro Ardizzone, Gabriele Bianchi Porro
Nature Clinical Practice. Gastroenterology & Hepatology
|
June 19, 2008
Is it possible to modify the clinical course of Crohn's disease?
Sandro Ardizzone, Gabriele Bianchi Porro
Inflammatory Bowel Diseases
|
September 26, 2008
How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?
Sandro Ardizzone, Gabriele Bianchi Porro
Drug Safety
|
July 13, 2002
Comparative tolerability of therapies for ulcerative colitis
Sandro Ardizzone, Gabriele Bianchi Porro
The American Journal of Gastroenterology
|
May 7, 2010
To stent or not to stent?: palliative management of inoperable colorectal cancer
Gianpiero Manes, Dario Callegaro, Sandro Ardizzone
Journal of Crohn'S & Colitis
|
December 4, 2013
Pneumatosis intestinalis and perforation in Crohn's disease: worrisome or not?
Emilia Bareggi, Massimo Tonolini, Sandro Ardizzone
Therapeutic Advances in Gastroenterology
|
July 2, 2016
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease
Sandro Ardizzone, Gerolamo Bevivino, Giovanni Monteleone
World Journal of Gastrointestinal Endoscopy
|
March 29, 2019
Endoscopic retrograde cholangiopancreatography, lights and shadows: Handle with care
Raffaele Salerno, Nicolò Mezzina, Sandro Ardizzone
Page
of 18